Genomic signatures characterize leukocyte infiltration in myositis muscles
Authors:
- Wei ZhuWZWei Zhu
- Katie StreicherKSKatie Streicher
- Nan ShenNSNan Shen
- Brandon W HiggsBHBrandon W Higgs
- Chris MorehouseCMChris Morehouse
- Lydia GreenleesLGLydia Greenlees
- Anthony A AmatoAAAnthony A Amato
- Koustubh RanadeKRKoustubh Ranade
- Laura RichmanLRLaura Richman
- David FiorentinoDFDavid Fiorentino
- Bahija JallalBJBahija Jallal
- Steven A GreenbergSGSteven A Greenberg
Open Access
- 21 November 2012
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 5 (1) , 53
Abstract
Leukocyte infiltration plays an important role in the pathogenesis and progression of myositis, and is highly associated with disease severity. Currently, there is a lack of: efficacious therapies for myositis; understanding of the molecular features important for disease pathogenesis; and potential molecular biomarkers for characterizing inflammatory myopathies to aid in clinical development. In this study, we developed a simple model and predicted that 1) leukocyte-specific transcripts (including both protein-coding transcripts and microRNAs) should be coherently overexpressed in myositis muscle and 2) the level of over-expression of these transcripts should be correlated with leukocyte infiltration. We applied this model to assess immune cell infiltration in myositis by examining mRNA and microRNA (miRNA) expression profiles in muscle biopsies from 31 myositis patients and 5 normal controls. Several gene signatures, including a leukocyte index, type 1 interferon (IFN), MHC class I, and immunoglobulin signature, were developed to characterize myositis patients at the molecular level. The leukocyte index, consisting of genes predominantly associated with immune function, displayed strong concordance with pathological assessment of immune cell infiltration. This leukocyte index was subsequently utilized to differentiate transcriptional changes due to leukocyte infiltration from other alterations in myositis muscle. Results from this differentiation revealed biologically relevant differences in the relationship between the type 1 IFN pathway, miR-146a, and leukocyte infiltration within various myositis subtypes. Results indicate that a likely interaction between miR-146a expression and the type 1 IFN pathway is confounded by the level of leukocyte infiltration into muscle tissue. Although the role of miR-146a in myositis remains uncertain, our results highlight the potential benefit of deconvoluting the source of transcriptional changes in myositis muscle or other heterogeneous tissue samples. Taken together, the leukocyte index and other gene signatures developed in this study may be potential molecular biomarkers to help to further characterize inflammatory myopathies and aid in clinical development. These hypotheses need to be confirmed in separate and sufficiently powered clinical trials.Keywords
This publication has 40 references indexed in Scilit:
- Permissive environment for B‐cell maturation in myositis muscle in the absence of B‐cell folliclesMuscle & Nerve, 2010
- The interferon-α signature of systemic lupus erythematosusLupus, 2010
- The role of microRNA in rheumatoid arthritis and other autoimmune diseasesClinical Immunology, 2010
- Dermatomyositis and Type 1 InterferonsCurrent Rheumatology Reports, 2010
- The type I IFN system in rheumatoid arthritisAutoimmunity, 2010
- Systemic sclerosis and lupus: Points in an interferon‐mediated continuumArthritis & Rheumatism, 2010
- Evidence for microRNA-mediated regulation in rheumatic diseasesAnnals of the Rheumatic Diseases, 2010
- Interferon‐stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophyAnnals of Neurology, 2010
- MicroRNA in autoimmunity and autoimmune diseasesJournal of Autoimmunity, 2009
- MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteinsArthritis & Rheumatism, 2009